Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation

(2016) Benjamin Izar et al.   Pigment Cell & Melanoma Research

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

(2015) Y. Koguchi et al.   CANCER RESEARCH

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

(2015) W. Deng et al.   SCIENCE

DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation

(2015) Ludovic Martinet et al.   Cell Reports

NKG2D Receptor and Its Ligands in Host Defense

(2015) L. L. Lanier   Cancer Immunology Research

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin

(2015) Jinyu Zhang et al.   Frontiers in Immunology

Matrix metallopeptidase 2 (MMP2) media la eliminación de MHC class I polypeptide-related sequence A (MICA) en el cáncer de células renales

(2014) F.Q. Yang et al.   Actas Urologicas Espanolas

Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells

(2014) Jeffrey W. Leong et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma

(2014) L. Ferrari de Andrade et al.   CANCER RESEARCH

MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques

(2014) Shunji Ikeshita et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression

(2014) A. Clayton et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein

(2014) P. Boutet et al.   JOURNAL OF IMMUNOLOGY

Immunological Visibility: Posttranscriptional Regulation of Human NKG2D Ligands by the EGF Receptor Pathway

(2014) P. Vantourout et al.   Science Translational Medicine

Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition

(2013) Eric O. Long et al.   Annual Review of Immunology

Regulation of Ligands for the NKG2D Activating Receptor

(2013) David H. Raulet et al.   Annual Review of Immunology

Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17

(2013) Guranda Chitadze et al.   INTERNATIONAL JOURNAL OF CANCER

Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis

(2013) Gang Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding

(2012) Leticia Huergo-Zapico et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

An six-amino acid motif in the α3 domain of MICA is the cancer therapeutic target to inhibit shedding

(2009) Xuanjun Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor-Associated MICA Is Shed by ADAM Proteases

(2008) I. Waldhauer et al.   CANCER RESEARCH

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

(2008) M. Jinushi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA